153 related articles for article (PubMed ID: 32882940)
1. Exploratory Study on Visual Acuity and Patient-Perceived Visual Function in Patients with Subretinal Drusenoid Deposits.
Grewal MK; Chandra S; Gurudas S; Bird A; Jeffery G; Sivaprasad S
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32882940
[TBL] [Abstract][Full Text] [Related]
2. Functional clinical endpoints and their correlations in eyes with AMD with and without subretinal drusenoid deposits-a pilot study.
Grewal MK; Chandra S; Gurudas S; Rasheed R; Sen P; Menon D; Bird A; Jeffery G; Sivaprasad S
Eye (Lond); 2022 Feb; 36(2):398-406. PubMed ID: 33750892
[TBL] [Abstract][Full Text] [Related]
3. Low-luminance visual acuity and microperimetry in age-related macular degeneration.
Wu Z; Ayton LN; Guymer RH; Luu CD
Ophthalmology; 2014 Aug; 121(8):1612-9. PubMed ID: 24661863
[TBL] [Abstract][Full Text] [Related]
4. Association of Low Luminance Questionnaire With Objective Functional Measures in Early and Intermediate Age-Related Macular Degeneration.
Thompson AC; Luhmann UFO; Stinnett SS; Vajzovic L; Horne A; Toth CA; Cousins SW; Lad EM
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):289-297. PubMed ID: 29340643
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Evaluation of Visual Function Impairments in Early and Intermediate Age-Related Macular Degeneration Patients.
Lad EM; Fang V; Tessier M; Rautanen A; Gayan J; Stinnett SS; Luhmann UFO
Ophthalmol Sci; 2022 Sep; 2(3):100173. PubMed ID: 36245764
[TBL] [Abstract][Full Text] [Related]
6. Phase 1 Clinical Trial of Elamipretide in Intermediate Age-Related Macular Degeneration and High-Risk Drusen: ReCLAIM High-Risk Drusen Study.
Allingham MJ; Mettu PS; Cousins SW
Ophthalmol Sci; 2022 Mar; 2(1):100095. PubMed ID: 36246187
[TBL] [Abstract][Full Text] [Related]
7. Subretinal Drusenoid Deposits and the Loss of Rod Function in Intermediate Age-Related Macular Degeneration.
Tan R; Guymer RH; Luu CD
Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4154-4161. PubMed ID: 30105370
[TBL] [Abstract][Full Text] [Related]
8. ASSOCIATION BETWEEN VISUAL FUNCTION AND SUBRETINAL DRUSENOID DEPOSITS IN NORMAL AND EARLY AGE-RELATED MACULAR DEGENERATION EYES.
Neely D; Zarubina AV; Clark ME; Huisingh CE; Jackson GR; Zhang Y; McGwin G; Curcio CA; Owsley C
Retina; 2017 Jul; 37(7):1329-1336. PubMed ID: 28633153
[TBL] [Abstract][Full Text] [Related]
9. Normal- and Low-Luminance Automated Quantitative Contrast Sensitivity Assessment in Eyes With Age-Related Macular Degeneration.
Ou WC; Lesmes LA; Christie AH; Denlar RA; Csaky KG
Am J Ophthalmol; 2021 Jun; 226():148-155. PubMed ID: 33529583
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the Classification of Age-Related Macular Degeneration Severity from the Northern Ireland Sensory Ageing Study Using a Measure of Dark Adaptation.
Higgins BE; Montesano G; Crabb DP; Naskas TT; Graham KW; Chakravarthy U; Kee F; Wright DM; Hogg RE
Ophthalmol Sci; 2022 Dec; 2(4):100204. PubMed ID: 36531574
[TBL] [Abstract][Full Text] [Related]
11. Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy: ReCLAIM NCGA Study.
Mettu PS; Allingham MJ; Cousins SW
Ophthalmol Sci; 2022 Mar; 2(1):100086. PubMed ID: 36246181
[TBL] [Abstract][Full Text] [Related]
12. Repeatability and Discriminatory Power of Chart-Based Visual Function Tests in Individuals With Age-Related Macular Degeneration: A MACUSTAR Study Report.
Dunbar HMP; Behning C; Abdirahman A; Higgins BE; Binns AM; Terheyden JH; Zakaria N; Poor S; Finger RP; Leal S; Holz FG; Schmid M; Crabb DP; Rubin GS; Luhmann UFO;
JAMA Ophthalmol; 2022 Aug; 140(8):780-789. PubMed ID: 35737401
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Subretinal Drusenoid Deposits in Older Persons with and without Age-Related Macular Degeneration, by Multimodal Imaging.
Zarubina AV; Neely DC; Clark ME; Huisingh CE; Samuels BC; Zhang Y; McGwin G; Owsley C; Curcio CA
Ophthalmology; 2016 May; 123(5):1090-100. PubMed ID: 26875000
[TBL] [Abstract][Full Text] [Related]
14. Scotopic thresholds on dark-adapted chromatic perimetry in healthy aging and age-related macular degeneration.
Grewal MK; Chandra S; Bird A; Jeffery G; Sivaprasad S
Sci Rep; 2021 May; 11(1):10349. PubMed ID: 33990634
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Autofluorescence in Non-Neovascular Age Related Macular Degeneration.
Chandra S; Grewal MK; Gurudas S; Sondh R; Bird A; Jeffery G; Chong V; Sivaprasad S
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831096
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Study of Dark Adaptation as a Functional Outcome Measure for Age-Related Macular Degeneration.
Chen KG; Alvarez JA; Yazdanie M; Papudesu C; Wong WT; Wiley HE; Keenan TD; Chew EY; Ferris FL; Cukras CA
Ophthalmology; 2019 Jun; 126(6):856-865. PubMed ID: 30278196
[TBL] [Abstract][Full Text] [Related]
17. Association of Visual Function Measures with Drusen Volume in Early Stages of Age-Related Macular Degeneration.
Pondorfer SG; Wintergerst MWM; Gorgi Zadeh S; Schultz T; Heinemann M; Holz FG; Finger RP
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):55. PubMed ID: 32232348
[TBL] [Abstract][Full Text] [Related]
18. Low luminance deficit and night vision symptoms in intermediate age-related macular degeneration.
Wu Z; Guymer RH; Finger RP
Br J Ophthalmol; 2016 Mar; 100(3):395-8. PubMed ID: 26250520
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between Rod-Mediated Sensitivity, Low-Luminance Visual Acuity, and Night Vision Questionnaire in Age-Related Macular Degeneration.
McGuinness MB; Fraser RG; Tan R; Luu CD; Guymer RH
Transl Vis Sci Technol; 2020 May; 9(6):30. PubMed ID: 32821527
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Visual Function Tests in Intermediate Age-Related Macular Degeneration.
Guymer RH; Tan RS; Luu CD
Transl Vis Sci Technol; 2021 Oct; 10(12):14. PubMed ID: 34636906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
